thalidomide has been researched along with trinitrobenzenesulfonic acid in 10 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 5 (50.00) | 29.6817 |
| 2010's | 4 (40.00) | 24.3611 |
| 2020's | 1 (10.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fayyazi, A; Fiebig, T; Germann, T; Hecker, M; Lienenlüke, B; Stojanovic, T | 1 |
| Ouyang, Q; Wang, X | 1 |
| Carneiro, AJ; Carvalho, AT; Carvalho, J; Castelo-Branco, M; Dines, I; Elia, C; Madi, K; Pereira Junior, FA; Pereira, MG; Rocha, E; Schanaider, A; Silv, F; Souza, H; Tortori, C | 1 |
| Medhi, B; Pandhi, P; Prakash, O; Saikia, UN | 2 |
| Avti, PK; Chakrabarti, A; Khanduja, KL; Medhi, B; Prakash, A | 1 |
| Al-Salami, H; Coussa-Charley, M; Fakhoury, M; Kahouli, I; Prakash, S | 1 |
| Huang, Y; Liang, Y; Xu, J; Zheng, C | 1 |
| Criado, G; Delgado, M; Diaz de la Guardia, R; García-Herrero, CM; Gonzalez-Rey, E; Lavoie, JR; Lopez-Millan, B; Menendez, P; O'Valle, F; Roca-Ho, H; Rosu-Myles, M | 1 |
| Jin, S; Li, D; Luan, X; Tian, F; Xie, Y; Yan, B | 1 |
10 other study(ies) available for thalidomide and trinitrobenzenesulfonic acid
| Article | Year |
|---|---|
Thalidomide impairment of trinitrobenzene sulphonic acid-induced colitis in the rat - role of endothelial cell-leukocyte interaction.
Topics: Animals; CD40 Ligand; Cell Adhesion; Colitis; Colon; Endothelium; Gene Expression Regulation; Humans; Interleukin-8; Leukocytes; Male; Mice; Nitric Oxide Synthase; Nitric Oxide Synthase Type II; Rats; Rats, Wistar; Thalidomide; Trinitrobenzenesulfonic Acid; Vascular Cell Adhesion Molecule-1 | 2001 |
[Study the effect and mechanism of thalidomide in model of inflammatory bowed disease].
Topics: Animals; Colitis, Ulcerative; Crohn Disease; Female; Inflammatory Bowel Diseases; NF-kappa B; Oxazolone; Rats; Rats, Sprague-Dawley; Thalidomide; Trinitrobenzenesulfonic Acid | 2005 |
Therapeutic and prophylactic thalidomide in TNBS-induced colitis: synergistic effects on TNF-alpha, IL-12 and VEGF production.
Topics: Animals; CD4-Positive T-Lymphocytes; Colitis; Colon; Gene Expression Regulation; Immunosuppressive Agents; Interleukin-12; Intestinal Mucosa; Macrophages; Male; Rats; Rats, Wistar; Thalidomide; Trinitrobenzenesulfonic Acid; Tumor Necrosis Factor-alpha; Vascular Endothelial Growth Factor A | 2007 |
Effect of different doses of thalidomide in experimentally induced inflammatory bowel disease in rats.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Colitis, Ulcerative; Disease Models, Animal; Female; Gastrointestinal Agents; Inflammatory Bowel Diseases; Male; Malondialdehyde; Peroxidase; Rats; Rats, Wistar; Sulfasalazine; Thalidomide; Trinitrobenzenesulfonic Acid; Tumor Necrosis Factor-alpha | 2008 |
Intestinal inflammation and seizure susceptibility: understanding the role of tumour necrosis factor-alpha in a rat model.
Topics: Animals; Brain; Catalase; Colitis; Colon; Disease Models, Animal; Female; Glutathione Peroxidase; Lipid Peroxidation; Male; Pentylenetetrazole; Rats; Rats, Wistar; Seizures; Superoxide Dismutase; Thalidomide; Trinitrobenzenesulfonic Acid; Tumor Necrosis Factor-alpha | 2009 |
Effect of combination of thalidomide and sulfasalazine in experimentally induced inflammatory bowel disease in rats.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Colon; Disease Models, Animal; Drug Therapy, Combination; Female; Immunosuppressive Agents; Inflammatory Bowel Diseases; Intestinal Mucosa; Male; Rats; Rats, Wistar; Sulfasalazine; Thalidomide; Treatment Outcome; Trinitrobenzenesulfonic Acid; Tumor Necrosis Factor-alpha | 2011 |
Use of artificial cell microcapsule containing thalidomide for treating TNBS-induced Crohn's disease in mice.
Topics: Alginates; Animals; Anti-Inflammatory Agents; Biomarkers; Capsules; Chemistry, Pharmaceutical; Colitis; Colon; Disease Models, Animal; Gastrointestinal Agents; Inflammation Mediators; Interleukin-1beta; Interleukin-6; Male; Mice; Mice, Inbred BALB C; Neutrophil Infiltration; Particle Size; Peroxidase; Polylysine; Solubility; Technology, Pharmaceutical; Thalidomide; Time Factors; Trinitrobenzenesulfonic Acid; Tumor Necrosis Factor-alpha | 2014 |
Efficacy of thalidomide on trinitrobenzene sulfonate-induced colitis in young rats and its mechanism.
Topics: Animals; Colitis; Cytokines; Inflammatory Bowel Diseases; Interleukin-10; Interleukin-1beta; NF-kappa B; Rats; Rats, Sprague-Dawley; Thalidomide; Trinitrobenzenesulfonic Acid; Tumor Necrosis Factor-alpha | 2014 |
Therapeutic effect of the immunomodulatory drug lenalidomide, but not pomalidomide, in experimental models of rheumatoid arthritis and inflammatory bowel disease.
Topics: Animals; Anti-Inflammatory Agents; Arthritis, Experimental; Collagen Type II; Dextran Sulfate; Disease Models, Animal; Immunologic Factors; Inflammatory Bowel Diseases; Lenalidomide; Male; Mice; Mice, Inbred C57BL; Thalidomide; Trinitrobenzenesulfonic Acid | 2017 |
Protective Effect of Thalidomide on 2,4,6-Trinitrobenzenesulfonic Acid-Induced Experimental Colitis in Rats via the Inhibition of T Helper 17 Cells.
Topics: Animals; Colitis; Colon; Rats; Rats, Sprague-Dawley; Th17 Cells; Thalidomide; Trinitrobenzenesulfonic Acid | 2020 |